AstraZeneca

The initiative is based on a strategic partnership between the company and Jerusalem Venture Partners, Microsoft, Israeli entrepreneur Morris Kahn and others.

Funds will be used to acquire more data sets and develop AI analysis.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer.

Over the last two years, big pharma has gotten behind the idea of smartphone-connected inhalers for asthma and COPD in a big way.

Propeller Health is working with Boehringer Ingelheim.

Pharma company AstraZeneca has publicly released preclinical data from more than 50 of its medicines in order to find new drug combinations for cancer treatments.

Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.

AstraZeneca has partnered with New Zealand-based Adherium Limited, which offers a mobile-enabled inhaler, to incorporate digital health offerings into AstraZeneca’s patient support programs for people with COPD and asthma.

AstraZeneca has partnered with mobile-enabled health coaching services company Vida to launch an app, called Day-by-Day, that helps patients who are recovering from a heart attack, according to Fortune.